Preserving long-acting contraception through counseling
Effect of Structured Counseling on Continuation Rates of Long Acting Reversible Contraception Among Clients Requesting Early Removal: A Multicenter Randomized Controlled Trial (PLACE Trial)
This trial will test whether structured, culturally sensitive counseling helps women in Islamabad who come for early removal of an IUD or Jadelle implant continue using their long-acting contraception.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 900 (estimated) |
| Ages | 18 Years to 49 Years |
| Sex | Female |
| Sponsor | Pakistan Institute of Medical Sciences Government |
| Locations | 3 sites (Islamabad, Islamabad and 2 other locations) |
| Trial ID | NCT07271836 on ClinicalTrials.gov |
What this trial studies
This multicenter randomized trial will enroll women at three federal family planning clinics in Islamabad who present for early removal of a copper-T IUD or a Jadelle implant. Participants will be randomly assigned to receive standardized, culturally sensitive counseling aimed at addressing concerns and encouraging continuation, or to receive standard care where the device is removed on request without counseling. The primary outcome is continuation of the LARC method after the counseling encounter, compared between the two groups. Recruitment begins December 15, 2025, and providers at intervention sites receive specific training in the structured counseling protocol.
Who should consider this trial
Good fit: Women attending the three participating Islamabad family planning clinics who request removal of a copper-T IUD or Jadelle implant within two years of placement and who can give informed consent are eligible.
Not a fit: Women who decline counseling, who require removal for medical indications, or who are unable to provide informed consent are unlikely to benefit from the intervention.
Why it matters
Potential benefit: If successful, the counseling approach could increase continued use of effective LARC methods and reduce unintended pregnancies among participants.
How similar studies have performed: Previous contraception counseling interventions have shown mixed but generally positive effects on method continuation and satisfaction, so this approach builds on some prior evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women presenting at the clinics exclusively for removal of a copper-T IUD or Jadelle subdermal implant within 2 years of use and within the first 2 months of the study. Exclusion Criteria: * Women not wishing to participate or unable to provide informed consent.
Where this trial is running
Islamabad, Islamabad and 2 other locations
- Rhs 'A' Center Federal Government Poly Clinic (Fgpc) — Islamabad, Islamabad, Pakistan (Recruiting)
- RHS 'A' CENTER Mother and Child Health Centre Aabpara — Islamabad, Islamabad, Pakistan (Recruiting)
- RHS-A centre, Pakistan Institute of Medical Sciences — Islamabad, Islamabad, Pakistan (Recruiting)
Study contacts
- Study coordinator: Dr. Muhammad I Khan, MBBS
- Email: ibrahim.k2000@gmail.com
- Phone: +923325467034
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.